Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
- - - - - - - 14.24M
26.99x4.29x1.9x5.78x17.29x20.29x1.74% 81.33B
18.58x1.76x-0.78x3.56x10.55x12.13x0.52% 57.33B
54.26x6.08x1.99x13.05x30.99x42.32x-.--% 53.86B
33.32x3.08x-5.15x5.03x16.65x24.78x0.81% 38.73B
338.62x9.13x-0.68x11.21x154.66x415.43x-.--% 19.4B
359.37x75.21x20.85x126.76x233.36x242.83x - 18.86B
11.2x0.99x-72.36x2.05x6.25x6.29x-.--% 18.31B
14.77x2.59x0x2.04x7.05x6.92x-.--% 13.14B
-3.06x1.54x-0.3x0.8x12.87x4.33x-.--% 12.09B
17.6x1.72x0.37x2.99x10.2x11.88x-.--% 10.99B
586.48x - 21x - - - 0.04% 10.58B
20.82x2.16x1.3x3.61x10.03x15.29x-.--% 9.69B
12.15x3.59x0.07x4.39x9.6x21.19x0.82% 9.42B
-16.17x-4.52x106.59x22.12x-28.95x-23.38x-.--% 8.83B
19.75x1.29x0.12x2.13x8.78x11.88x-.--% 8.51B
27.36x1.52x-2.34x2.09x19.88x21.66x0.67% 6.79B
19.31x1.36x1.96x4.53x14.59x16.41x-.--% 6.44B
16.78x1.68x-3.04x - - - - 5.71B
Average 86.56x 6.67x 3.97x 13.26x 33.36x 53.14x 0.29% 20.53B
Weighted average by Cap. 72.62x 6.95x 0.59x 12.36x 33.27x 51.12x 0.59%
Biopharmaceuticals